Clicky

GenSight Biologics S.A(G49N) News

Date Title
Apr 23 GenSight Biologics Annual General Meeting on May 13, 2025
Feb 12 GenSight’s Optic Neuropathy gene therapy sustains efficacy over five years
Feb 12 GenSight Biologics Announces Five-Year Efficacy and Safety Results for LUMEVOQ® Gene Therapy at the Conclusion of the REFLECT Study